MUC16 c.7219C>A ;(p.L2407I)

Variant ID: 19-9084596-G-T

NM_024690.2(MUC16):c.7219C>A;(p.L2407I)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021

Variant appearance in text: MUC16: 7219C>A; L2407I
PubMed Link: 34887858
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Bmc Genomics
Cai, Weijing W; Zhou, Dapeng D; Wu, Weibo W; Tan, Wen Ling WL; Wang, Jiaqian J; Zhou, Caicun C; Lou, Yanyan Y
Publication Date: 2018-08-03

Variant appearance in text: MUC16: L2407I
PubMed Link: 30075702
Variant Present in the following documents:
  • Main text
  • 12864_2018_4958_MOESM4_ESM.xlsx, sheet 1
  • 12864_2018_Article_4958.pdf
  • 12864_2018_4958_MOESM3_ESM.xlsx, sheet 1
  • 12864_2018_4958_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Genomic alterations in mucins across cancers.

Oncotarget
King, Ryan J RJ; Yu, Fang F; Singh, Pankaj K PK
Publication Date: 2017-09-15

Variant appearance in text: MUC16: L2407I
PubMed Link: 28978023
Variant Present in the following documents:
  • oncotarget-08-67152-s005.xls, sheet 1
View BVdb publication page